Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:31 pm Sale | 2024-09-30 | 13G | Harvard Bioscience, Inc. HBIO | 272 Capital LP | 1,555,820 3.600% | -1,383,458 (-47.07%) | Filing History |
| 2024-11-14 12:30 pm Purchase | 2024-09-30 | 13G | Cadiz Inc. CDZI | 272 Capital LP | 3,522,582 5.200% | 3,522,582 (New Position) | Filing History |
| 2024-02-14 08:48 am Sale | 2023-12-31 | 13G | The Arena Group Holdings, Inc. AREN | 272 Capital LP | 0 0.000% | -1,654,698 (Position Closed) | Filing History |
| 2024-02-14 08:46 am Sale | 2023-12-31 | 13G | Harvard Bioscience, Inc. HBIO | 272 Capital LP | 2,939,278 6.900% | -325,518 (-9.97%) | Filing History |
| 2023-10-27 4:30 pm Purchase | 2023-04-03 | 13D | Sequans Communications S.A. SQNS | 272 Capital LP | 18,005,506 18.500% | 10,057,286 (+126.54%) | Filing History |
| 2023-02-16 3:13 pm Unchanged | 2022-12-31 | 13G | The Arena Group Holdings, Inc. AREN | 272 Capital LP | 1,654,698 9.100% | 0 (Unchanged) | Filing History |
| 2023-02-16 3:11 pm Unchanged | 2022-12-31 | 13G | Harvard Bioscience, Inc. HBIO | 272 Capital LP | 3,264,796 7.800% | 0 (Unchanged) | Filing History |
| 2023-02-15 5:37 pm Sale | 2020-12-31 | 13G | inTEST Corporation INTT | 272 Capital LP | 0 0.000% | -836,918 (Position Closed) | Filing History |
| 2023-02-15 5:30 pm Purchase | 2022-11-29 | 13G | Harvard Bioscience, Inc. HBIO | 272 Capital LP | 3,264,796 7.840% | 3,264,796 (New Position) | Filing History |
| 2023-02-15 5:27 pm Purchase | 2022-05-09 | 13G | The Arena Group Holdings, Inc. AREN | 272 Capital LP | 1,654,698 9.070% | 1,654,698 (New Position) | Filing History |
| 2022-12-05 5:14 pm Purchase | 2022-12-01 | 13D | Sequans Communications S.A. SQNS | 272 Capital LP | 7,948,219 10.400% | 833,280 (+11.71%) | Filing History |
| 2022-10-18 5:01 pm Purchase | 2022-09-30 | 13D | CAMP4 Therapeutics Corporation CAMP | 272 Capital LP | 135,955 8.440% | 39,035 (+40.28%) | Filing History |
| 2022-09-06 5:00 pm Purchase | 2022-09-01 | 13D | Sequans Communications S.A. SQNS | 272 Capital LP | 7,114,939 9.300% | 1,349,606 (+23.41%) | Filing History |
| 2022-07-22 4:15 pm Purchase | 2022-07-12 | 13D | CAMP4 Therapeutics Corporation CAMP | 272 Capital LP | 96,920 6.170% | 37,117 (+62.07%) | Filing History |
| 2022-06-22 5:00 pm Purchase | 2022-06-21 | 13D | CAMP4 Therapeutics Corporation CAMP | 272 Capital LP | 59,803 3.810% | 904 (+1.53%) | Filing History |
| 2022-05-26 3:26 pm Purchase | 2022-05-12 | 13D | CAMP4 Therapeutics Corporation CAMP | 272 Capital LP | 58,899 3.760% | 58,899 (New Position) | Filing History |
| 2022-03-24 12:11 pm Purchase | 2022-03-15 | 13D | Sequans Communications S.A. SQNS | 272 Capital LP | 5,765,333 8.100% | 5,765,333 (New Position) | Filing History |
| 2021-01-20 11:44 am Purchase | 2020-12-31 | 13G | inTEST Corporation INTT | 272 Capital LP | 836,918 7.900% | 836,918 (New Position) | Filing History |